From a prognostic perspective, patients with low levels of HOTAIR in tumor tissues displayed significantly prolonged survival (13.4 vs. 9.5 months) and PFS (8.4 vs. 6.2 months) compared to those with high expression levels. The gene discussed is HOTAIR; the disease is neoplasm.